Global Thyroid Microwave Ablation Technology Exchange Conference (4th Session) Successfully Held Online


August 30, 2024 — The fourth session of Baird Medical’s Global Thyroid Microwave Ablation Technology Exchange Conference brought together top medical experts from both China and the United States for in-depth discussions on the latest developments and future trends in microwave ablation (MWA) technology. This academic event, hosted by Baird Medical, was a significant platform for international exchange in the field of thyroid disease management.

Key Highlights from the Conference

The conference began with an opening address by Dr. Ying Jiang, Chief Physician of Thyroid and Breast Surgery at Zhongshan Hospital, Fudan University. Dr. Jiang emphasized the transformative potential of MWA in thyroid treatment and the ongoing shift toward minimally invasive techniques. Her remarks set a positive tone for the event, encouraging a productive dialogue between participants.

Dr. Ying Huang from Shengjing Hospital of China Medical University delivered the first presentation, focusing on ultrasound-guided thermal ablation for thyroid nodules. She shared clinical data demonstrating the safety and efficacy of MWA, which garnered significant interest from U.S. doctors, who raised questions about surgical efficiency and optimization.

Dr. Jian Fei from Ruijin Hospital, Shanghai Jiao Tong University, provided a comprehensive overview of MWA’s application in thyroid cancer treatment. He highlighted the differences between MWA and radiofrequency ablation (RFA), noting MWA’s superior energy output and shorter treatment duration. His presentation led to a lively discussion, with U.S. doctors particularly interested in the comparative benefits of these two techniques.

Dr. Emad Kandil from Tulane University shared his clinical experience, presenting detailed insights from 40 MWA cases in thyroid cancer treatment. His session was highly praised for its practical value and served as a key reference for applying MWA in challenging cases.

Closing Remarks

The conference concluded with a summary by Dr. Ying Jiang, who expressed gratitude to all participants and reiterated the importance of continued collaboration. She emphasized that the shared insights and experiences will significantly contribute to the global advancement of MWA technology, paving the way for wider clinical adoption.

Fostering Global Collaboration

The event not only showcased the latest research but also reinforced Baird Medical’s role as a leader in promoting minimally invasive treatments. By facilitating this high-level exchange, Baird Medical continues to strengthen international partnerships and drive innovation in thyroid care.

Disclaimer: This content is for informational purposes only and does not constitute a clinical endorsement. Please consult a qualified healthcare professional for treatment guidance.